Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well BooDog, it would be nice if it bounced and then rode free again, but for now it's down .004.
I admire your optimism.
What makes you think it will bounce, the Q2 reporting in August 2017? Or some other reason?
My general opinion on this for the rest of the year is poor sales, high SG&A and a low PPS.
Perhaps, if the ANDA Fluticare got approved and INNV didn't dilute the stock anymore this year, the PPS might go up.
Twistedfreak, it appears that you've located the fraudulent, unethical and illegal con-artistry of Dr.Damaj.
Novalere Holdings was incorporated on 1/20/15 in Delaware.
Novalere changed from Massachusetts corp to Delaware corp on 3/10/2015.
Novalere pulled out of Massachusetts corp on 2/4/2016.
Based on this latest discovery, the ANDA for OTC Fluticare is null and void.
My74nova, I can see that you sure are a genius and very patient as well.
Blackbandit, you're $15 dollar price per share at the end of June was wrong.
Has anyone ever heard of the Dendreon effect? DNDN, filed for bankruptcy in November 2014 after having already received FDA approval for their prostate cancer drug, Provenge in April 2010.
Also, there was a Bear Raid on April 28, 2009, when DNDN stock plunged from $24.50 to $7.50 in 75 seconds. FINRA let the trades stand and the SEC did nothing until Senator Chuck Grassley went to the SEC's Office of the Inspector General and demanded answers and got the run around...
Investing in biotechs appears to be similar to gambling.
Shorting, Dilution, Reverse Splits, Market Makers Manipulation, Loan-Shark-Style-Financing, Bear Raids, The Dendreon efffect, Corrupted FDA, Martin Shkreli, Black Swan Events and Non-Audited Financial Reporting.
Has anyone ever heard of the Dendreon effect? DNDN, filed for bankruptcy in November 2014 after having already received FDA approval for their prostate cancer drug, Provenge in April 2010.
Also, there was a Bear Raid on April 28, 2009, when DNDN stock plunged from $24.50 to $7.50 in 75 seconds. FINRA let the trades stand and the SEC did nothing until Senator Chuck Grassley went to the SEC's Office of the Inspector General and demanded answers and got the run around...
Investing in biotechs appears to be similar to gambling.
Shorting, Dilution, Reverse Splits, Market Makers Manipulation, Loan-Shark-Style-Financing, Bear Raids, The Dendreon efffect, Corrupted FDA, Martin Shkreli, Black Swan Events and Non-Audited Financial Reporting.
God Bless America! Happy July 4th Independence day!
I'm amazed with INNVs stability today!!! It just goes to show what a great company we have here!
TrueTrades, whether it was Hikma or Hi tech India who applied for the ANDA for OTC Fluticare on behalf of INNV...
Wouldn't there be a public way to find out if there was a CLR issued, because the manufacturer was denied approval, due to some sort of manufacturing deficiency that was found and not corrected on time?
I highly doubt there was any manufacturing deficiency found, because Fluticare is easy to make/compound and Hikma or Hi tech India manufacture other drugs, without issue, in fact I doubt the FDA would even want to inspect those facilities, because they are already proven.
If the FDA did an entire manufacturing plant reinspection for every new drug, or every existing drug that went OTC, that would be dumb and time consuming and expensive. (On the other hand Ho Tech India is a 3rd world country, so who knows...)
Also, if GSK sued with a patent infringement challenge, wouldn't that be available to find as a matter of public record?
I doubt GSK or Bayer or any of them would sue with a patent infringement challenge, but I guess it is possible, they have probably done that several times in the past with other drugs.
Like I said earlier, in INNVs latest presentation the ANDA for OTC Fluticare was still noted on a slide, so it should/could still happen.
Ok TrueTrades, based on what you mentioned, I don't think INNV/Novalare (or whoever was the manufacturer, ANDA) ever received any FDA, CLR regarding Fluticare.
My opinion is that Dr.Damaj should never have mentioned a possible FDA Fluticare OTC approval date, he should have said that it could take up to 12/31/17 barring any glitches.
It appears to me that big pharma GSK/Bayer has been influential in regard to getting the FDA to drag it's feet regarding Fluticare review/approval.
Based on this, I think the FDA might take until 12/31/17 to approve/deny Fluticare and possibly all the way up until 1/31/18.
I don't think GSK/Bayer are able to instruct the FDA regarding to many nasal spray options being on the market, because that would F over part of our free market economy.
However, I do think the FDA would naturally concentrate on review fast tracked anti cancer drugs, for example, versus nasal sprays.
If and when the ANDA for Fluticare is approved, I don't think it will make any difference in INNVs share price.
In my opinion, the only thing that will effect the PPS in a positive direction is increased sales and lowered costs, equaling profitability.
Ok jbdiver, so that tells me that INNV did not even receive 1 CLR from the FDA in regard to Fluticare, so the FDA just must be dragging out the full 36 months time-frame in favor of big pharma, like GSK and Bayer.
Lol, ok now I understand and ya that was a funny movie.
Twistedfreak, what does DOBA mean?
Ok TrueTrades, I think I understand and I'm not arguing with you about anything. I think the latest INNV presentation still lists an aNDA for Fluticare, which is different from the side deal with Westward.
TrueTrades, are you saying that INNV received 2 or 3 CRLs from the FDA for Fluticare, which has set back review/approval for an additional 6 months at a time, so that's why it has seemingly been taking about an extra 18 months or so for Fluticare?
Is so, where is the proof of that? I wonder what the reason for a CRL would be, a simple typo or missing period or smudge-mark on the paperwork?
INNV hasn't directly or inderctly submitted any other drugs to the FDA, so you have to be referencing Fluticare, correct?
If INNV received a couple/few CRLs regarding Flutciare from the FDA, that's just more proof to me that GSK/Bayer either got early Flonase/Clarispray OTC approval, either because they developed the drug and/or paid off the FDA for fast track and to slow down INNVs approval.
If the longest it could take for Fluticare OTC approval is 36 months, plus 3 CRLs, add an 18 additional months, for a total of 54 months, in other words 4.5 years.
Where did Adrock go? He always used to say, "but what do I know?"
Drug approvals by link;
https://www.accessdata.fda.gov/scripts/cder/daf/
Will the original ANDA fluticare ever get approval? What about European approval?
FLUTICASONE PROPIONATE
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #076300 | OINTMENT;TOPICAL | Prescription | FOUGERA PHARMS
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #076451 | CREAM;TOPICAL | Prescription | FOUGERA PHARMS
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #076504 | SPRAY, METERED;NASAL | Prescription | WEST-WARD PHARMS INT
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #076633 | CREAM;TOPICAL | Prescription | TOLMAR
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #076668 | OINTMENT;TOPICAL | Prescription | PERRIGO NEW YORK
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #076793 | CREAM;TOPICAL | Prescription | PERRIGO NEW YORK
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #076865 | CREAM;TOPICAL | Discontinued | NESHER PHARMS
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #077055 | CREAM;TOPICAL | Prescription | G AND W LABS
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #077145 | OINTMENT;TOPICAL | Discontinued | TARO PHARM INDS
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #077168 | OINTMENT;TOPICAL | Prescription | G AND W LABS
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #077538 | SPRAY, METERED;NASAL | Prescription | APOTEX INC
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #077570 | SPRAY, METERED;NASAL | Prescription | HI TECH PHARMA
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #078492 | SPRAY, METERED;NASAL | Prescription | WOCKHARDT
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #090759 | LOTION;TOPICAL | Prescription | GLENMARK GENERICS
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #091553 | LOTION;TOPICAL | Prescription | PERRIGO ISRAEL
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #207957 | SPRAY, METERED;NASAL | Over-the-counter | WEST-WARD PHARMS INT
FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE) | ANDA #208150 | SPRAY, METERED;NASAL | Over-the-counter | APOTEX INC
Remember these posts?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=123992810
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=124101991
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=124000591
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=124120954
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=124001683
Where is Honeycomb777? Did he sell his INNV? I could sell my INNV for a 65% loss now? Should I wait a bit longer, to sell it for a 99% loss? I think I'll wait for the 99% loss...
Batermere or anyone, how long can Ovit stay dormant, before it has to file for bankruptcy? Or, how long can it be dormant, before it has to be merged or shelled into another company? Or, are there no time limits on bankruptcy/dormancy?
That must be why it's going down, all the fire-sale, profit taking. Or, is it the lawsuit causing it to go down?
So, you're not going to give any thought to the lawsuit? Going from 2 pills per day, to 1 would be great, but first we have to get the current dose FDA approved, then reformulate, then redo the trials, phase 1, 2 and 3, then another ANDA, then another CLR, then another trial and then another lawsuit.
How high we go from here depends a lot on the lawsuit.
What are those shares doing in holdings? Didn't someone buy those shares?
Go to the OVIT forum and look at my latest post.
I hear you Batermere and I agree with you. I lost the same amount on OVIT, if not a bit more, which I think made me desperate to try and make some back, which caused me to lose more money on GPRO, LPCN, OXYGN/MATN and GALE. I would have done better with AAPL and COST for example.
If anyone cares, the bottom of ACAD, MATN and GPRO are basically in now, so invest a bit if you want, but don't throw too much in.
When desperation sets in, I think that's especially when the Murphy's law style of garbage, of whatever can go wrong will go wrong, really kicks in big time.
I guess the only person I came blame for my INNV loses is me, but if I would have know they don't know how to advertise on the Internet and that they were not even profitable, I probably would have thought twice.
I'm not advertising for INNV and I hate Amway, but if I, or my immediate family had a condition, that INNV had a product for, I would recommend the INNV product, without high pressure tactics and never mention it again.
It's amazing how with INNV and other OTC companies, they have a hype time of a year or two and then people catch on and the PPS either tanks or stays down due to reality, not hype.
It's just strange the way things were portrayed, that Damaj took Apricus from 16 cents to 6 dollars per share, they could have indicated that there were reverse splits in order to do so.
It could have been indicated that Damaj didn't exactly, really put in his own money into INNV in the full sense, because apparently he's taking high interest payments to make all that loaned money back, when in an interview he said he wouldn't take a salary until INNV was profitable...
(I know technically there is a difference between taking interest payments and a salary, but still it's sort of like Bill Clinton saying..."Well, it depends on what the definition of is, is.")
It could have been indicated that Damaj was awarded a bunch of INNV shares when he became the CEO and that he didn't have to pay for them. (I guess that's just common sense to know.)
Everything I noted above isn't exactly a lie on Damaj's part, but it's not exactly the complete truth either, Damaj, positively embellished everything to the extreme.
I'm not saying I could run a company better and I'm not expecting the CEO Damaj to present INNV in a negative light, but at the very least, I would have expected this...
Never, never over promise and under deliver. Always under "promise" and over deliver, just over delivering on sales/profits/forecasts, could have done a lot for the PPS.
Never hint at "promising" approval from the FDA, just say that INNV obtained the original ANDA to sell Fluticare OTC world wide via the manufacturer, if and when approval is received and that it could happen at anytime within the next 3 years. Damaj could say that typically it takes 2 years. Damaj "basically promised" with all his Fluticare hyping from 2015, through early 2017, until he finally shut his mouth.
Also, Damaj never should have given away shares of INNV prior to Fluticare approval.
I'm sure there are some things that I/we don't know, but geez it sure does seem like some missteps on Damaj's part.
I don't have allergies, but just due to the nostalgia of Fluticare, I would buy some of it, just because I've been waiting so damn look for Fluticare approval.
I wonder if I should keep buying more INNV to average down further? What scares me though, is that I chased OVIT down into bankruptcy.
I'd like to see INNV get OTC rights to Viagra and then also sell it with Vessle.
It also scares me when honeycomb states stuff like, now way Q2 will be below Xamount, that just jinxes it to be far less.
Wow Batermere, I never thought you'd change your tune on INNV, I don't know if part of the reason was due to me being so negative about it or not, but last I knew...I thought you said this was the calm before the storm.
I am so tired of losing money, that I think I might wait indefinitely for as many years as it takes, to hopefully at least break even on INNV.
I hope INNV is in business for years and has good and helpful products and good sales.
I guess, I'll just be screwed on INNV for a long time to come?
HC,keep in mind, that sales don't matter if the SG&A costs are too high. I admire your enthusiasm, but you are usually wrong and I wish you'd use your time and energy to contact Damaj and get him to advertise on the Internet/Google and on the radio.
Shawn, I don't have gains to offset, are you kidding? I have losses to offset! I think Q2 2017 will be a big bust and even if sales we're ok, it wouldn't matter, because Damaj is using 4million in SG&A and scamming to get 2million in sales!
Jbdiver, that's what happens to penny stock scams like this, they pump for a year or so and then tank, take your money and go out of business. Keep in mind if Trumps travel ban ever went into effect, Damaj couldn't be allowed in the USA, to run INNV.
Shawn, my first vibe when I saw an interview with Damaj was that he was a major conman, but people kept pumping and like a fool I listened. Do you think I should bale out now at a 60% loss? How long do you think it will take until INNV declares bankruptcy? Or do you think Damaj declare dormancy? Can we sue Damaj, or does he get off freely like Dr.Wiess of OVIT?
Shawn, I took a look at the Zacks rating for INNV and it was a major dud. I never should have invested in INNV. I will try to be smarter and more patient from now on.
Looking forward to bankruptcy!
Remember when some posters on here actually thought INNV trading would be "halted" if they obtained the original ANDA Fluticare approval?
Lol, ya like Costco or GSK were halted when they started selling generic and over the counter nasal spray.
It's only a matter of time until people sue INNV and Dr.Damaj dilutes on a daily basis to cover his legal expenses.
Mike007, trading is probably slow because people have lost faith in INNV.
How are things at Infamous Nutraceutical's today? We are down and diluted! No amount of press releases or fluti pumping will get the pps up, it's up to profits now, which Damaj won't allow, because he's pocketing any profit and he doesn't care to advertise digitally. Even if the manufacturer/INNV received the ANDA fluticare approval, it's too late for anything good to happen with the PPS, because Damaj pumped it too much and because everybody and their brother is selling a flut-spin-off generic.
Well, the new INNV board will make it at least until INNV files for bankruptcy.
Terrible OVIT nightmare lastnight!!! All of the sudden, out of the blue...OVIT opened at $2-3 dollars per share!!! It was reverse shelled into another company that had a viable protocol for testing and marketing...
This meant that not only did I lose my initial investment, but it also meant that I entirely missed out on more than doubling my investment profit! (The painful lesson to me was to be more patient.)
OVIT can't stay dormant forever, somethings going to happen, either it will be merged or or reverse shelled into another company, or it will have to officially go from dormant to bankrupt, to out of business.
Why is it taking so long for Dr.Weiss to take this from dormancy to bankruptcy?